Responses
Other responses
Jump to comment:
- Published on: 15 March 2016
- Published on: 15 March 2016
- Published on: 15 March 2016Re:Are DPP-4 inhibitors free from risk of hospitalization for heart failure?Show More
Having carefully read the letter by Donzelli et al., we would like to thank the writers for the comments. It is our intention to stick strictly to the results of our analysis and not to address topics such as glycemic targets and benefit of vegetarian diet in type 2 diabetes which have nothing to do with our paper. By using a validated epidemiological methodology in a real life population, our analysis aimed to see whe...
Conflict of Interest:
None declared. - Published on: 15 March 2016Are DPP-4 inhibitors free from risk of hospitalization for heart failure?Show More
The case-control study [1] on administrative data did not find increased risk of hospitalization for heart failure (HF) associated with the use of DPP-4 inhibitors (DPP-4is), versus any other antidiabetic treatment. In DPP-4is users the OR for admission for HF was 1.00 (0.94 to 1.07), with a non-significant 1.01 and 1.02 for incident and recurrent HF, respectively. All-cause mortality was 6% lower in DPP-4i users, whereas...
Conflict of Interest:
None declared.